cjasn.asnjournals.orgClinical Journal of the American Society of Nephrology

You may be trying to access this site from a secured browser on the server. Please enable scripts and reload this page. ASN Publications CJASN JASN Kidney360 ASN Publications CJASN JASN Kidney360 Log in or Register Subscribe to journal Subscribe Get new issue alerts Get alerts Enter your Email address: Wolters Kluwer Health may email you for journal alerts and information, but is committed to maintaining your privacy and will not share your personal information without your express consent. For more information, please refer to our Privacy Policy. Subscribe to eTOC Secondary Logo Journal Logo All Articles Images Videos Podcasts Blogs Advanced Search Toggle navigation Subscribe Register Login Articles Current Issue Published Ahead of Print Archives Subject Collections Authors & Reviewers Submit to CJASN Information for Authors Reviewer Guidelines Trainees Peer Review Program Prize Competition Podcasts Journal Info About CJASN Editorial Team CJASN Impact CJASN Recognizes More Alerts Advertising Subscriptions Reprints All Articles Images Videos Podcasts Blogs Advanced Search Announcements ​​​Save time with the CJASN, JASN, and Kidney360 submission process. If you are submitting original research, you automatically qualify for simple submission. See the flyer​ for more information.​​ ​ The ASN Journal editors recently created a new ASN Journals’ Editorial Board​ . This broader editorial board includes editors who work across all three journals to support JASN, CJASN, and Kidney360.​ ​ Latest Articles A Quality Systems Perspective on Sensitization and Kidney Allocation System Changes Association of Preterm Birth with Adverse Glomerular Disease Outcomes in Children and Adults Unexplained Metabolic Alkalosis in an Athlete: Don’t Sweat It A National Survey of Pregnancy and Parenthood Among Nephrology Trainees: A Focus on Nephrology Fellowship Development and external validation of a multidimensional deep learning model to dynamically predict kidney outcomes in IgA nephropathy View More Recent Articles Current Issue May 2024 - Volume 19 - Issue 5 Editor-in-Chief: Connie Rhee, MD, MSc ISSN: 1555-905X Online ISSN: 1555-905X Frequency: monthly, 12x Impact Factor: 9.8 eTOC Alert CJASN Impact ​Check out the ​ top 5 CJASN articles​ by citation, usage, and Altmetrics score over the last 12 months, as well as podcasts highlighting new CJASN articles. ​ Recent Podcasts Resveratrol in CKD Effect of Resveratrol on Endothelial Function in Patients with CKD and Diabetes A Randomized Controlled Trial Metabolomics and Neurocognition Circulating Metabolomic Associations with Neurocognitive Outcomes in Pediatric CKD Tubular Biomarkers and Kidney Histopathology in Diabetes Associations of Biomarkers of Tubular Injury and Inflammation with Biopsy Features in Type 1 Diabetes Chronic Interstitial Nephritis in Agricultural Communities: Observational and Mechanistic Evidence Supporting the Role of Nephrotoxic Agrochemicals : Figure 3 Patient-Centered Home Hemodialysis: Approaches and Prescription : Figure 1 Trust, Multidimensional Health Literacy, and Medication Adherence among Patients Undergoing Long-Term Hemodialysis : Figure 2 Histologic and Clinical Factors Associated with Kidney Outcomes in IgA Vasculitis Nephritis : Figure 2 Tweets by CJASN CJASN Peer Review ​​​​​CJASN is grateful for the many reviewers who contributed their time and insights in 2023​ . ​Never Miss an Issue Get new journal Tables of Contents sent right to your email inbox Get New Issue Alerts Browse Journal Content Current Issue Alerts Published Ahead of Print RSS Feeds Most Popular Reprints Archive Subscriptions Register on the website Subscribe Get eTOC Alerts For Journal Authors Submit to CJASN Author Instructions Customer Service Contact us at: Support: Submit a Service Request TEL: 800-638-3030 (within the USA) 301-223-2300 (outside of the USA) Cookie Settings Privacy Policy Legal Disclaimer Terms of Use Open Access Policy Your California Privacy Choices Copyright © 2024 Wolters Kluwer Health, Inc. and/or its subsidiaries. All rights...